Ryan Joyce

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizations”.

The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizations

Medicinal Chemistry Research(2022)10.1007/s00044-022-02951-6

N/A

0DataRank · unranked

119 citations

Vivian W. Hu, Jun Wang, Ryan Joyce

Exploring diverse reactive warheads for the design of SARS-CoV-2 main protease inhibitors

European Journal of Medicinal Chemistry(2023)10.1016/j.ejmech.2023.115667

N/A

0DataRank · unranked

27 citations

M. Sacco, Haozhou Tan, Kan Li, Ryan Joyce, Xiujun Zhang +3 more

Inhibitors of Keap1-Nrf2 protein-protein interaction reduce estrogen responsive gene expression and oxidative stress in estrogen receptor-positive breast cancer

Toxicology and Applied Pharmacology(2023)10.1016/j.taap.2023.116375

N/A

0DataRank · unranked

15 citations

Husam Zahid, Ahmed R. Ali, Ryan Joyce, Ge Yang, Cassandra Winz +6 more